Kyu Pyo Kim

Title: Kyu Pyo Kim: Innovator in Cancer Treatment

Introduction

Kyu Pyo Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the suppression of cancer metastasis, which is a critical area in oncology.

Latest Patents

Kyu Pyo Kim holds a patent for a composition aimed at the treatment or metastasis suppression of cancers. This composition includes a p34 expression inhibitor or activity inhibitor as an active ingredient. The invention details how the knock-down of the p34 protein leads to monoubiquitination of PTEN, inducing its nuclear localization. This process inhibits the Akt pathway, which is associated with tumor survival, proliferation, and metastasis. As a result, the invention significantly reduces the clonogenic potential and tumor-forming ability of various cancer cells that express both PTEN and NEDD4-1. This innovative approach positions the p34 gene expression inhibitor or p34 protein activity inhibitor as a promising treatment or metastasis suppression agent for cancers.

Career Highlights

Throughout his career, Kyu Pyo Kim has worked with reputable organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research in cancer treatment.

Collaborations

Kyu Pyo Kim has collaborated with Dong Hoon Jin, contributing to advancements in cancer research and treatment methodologies.

Conclusion

Kyu Pyo Kim's innovative work in cancer treatment through his patented compositions showcases his dedication to improving therapeutic options for patients. His contributions are vital in the ongoing fight against cancer, and his research continues to inspire advancements in the field.